Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?
- PMID: 22493030
- PMCID: PMC3322549
- DOI: 10.1128/mBio.00061-12
Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?
Abstract
In contrast to usual laboratory conditions, most bacteria in the human body grow in biofilms. Encased in a structured matrix, many pathogens display heightened resistance to antibiotics. Pseudomonas aeruginosa lung infections in cystic fibrosis patients represent a prime example of the clinical challenges that antibiotic resistance in biofilms can represent. In the March 6, 2012 issue of mBio, Colin Hill and his colleagues report on experiments that add to the evidence that Pseudomonas phages are a potential treatment option for these infections.
Comment on
-
Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.mBio. 2012 Mar 6;3(2):e00029-12. doi: 10.1128/mBio.00029-12. Print 2012. mBio. 2012. PMID: 22396480 Free PMC article.
References
-
- Debarbieux L, et al. 2010. Bacteriophage can treat and prevent Pseudomonas aeruginosa lung infection. J. Infect. Dis. 201:1096–1104 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
